EyePoint Pharmaceuticals
EYPT
#10553
Rank
ยฃ25.68 M
Marketcap
ยฃ0.30
Share price
6.70%
Change (1 day)
-96.86%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -ยฃ0.23 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ2.78 Million. In 2025 the company made an earning of -ยฃ0.18 Billion a decrease over its 2024 earnings that were of -ยฃ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.23 Billion32.7%
2025 -ยฃ0.18 Billion63.24%
2024 -ยฃ0.11 Billion104.29%
2023 -ยฃ51.75 Million-29.88%
2022 -ยฃ73.8 Million87.2%
2021 -ยฃ39.42 Million38.58%
2020 -ยฃ28.45 Million-24.56%
2019 -ยฃ37.71 Million
2017 -ยฃ17.2 Million22.59%
2016 -ยฃ14.03 Million-8.02%
2015 -ยฃ15.26 Million-296.09%
2014 ยฃ7.77 M-174.02%
2013 -ยฃ10.51 Million37.42%
2012 -ยฃ7.65 Million-56.29%
2011 -ยฃ17.5 Million-1062.38%
2010 ยฃ1.81 M-250.43%
2009 -ยฃ1.21 Million-89.5%
2008 -ยฃ11.52 Million
2005 -ยฃ7.1 Million56.99%
2004 -ยฃ4.53 Million73.7%
2003 -ยฃ2.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-ยฃ1.61 Million-99.29% Bahamas
NRC Health
NRC
ยฃ11.01 M-104.85%๐Ÿ‡บ๐Ÿ‡ธ USA